Enzon Pharmaceuticals, Inc. (ENZN) Presents Data at 2009 EORTC Meeting
11/19/2009 8:04:47 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) to Present Data at EORTC-NCI-AACR
11/17/2009 9:27:08 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) to Sell Specialty Pharmaceuticals Business to the Sigma-Tau Group for $300 Million Plus up to $27 Million
11/9/2009 7:47:07 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Reports Third Quarter 2009 Results
11/3/2009 8:53:18 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) to Present at Newsmakers in the Biotech Industry Conference
9/11/2009 10:18:58 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
7/27/2009 11:11:57 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) to Present at BMO Focus on Healthcare Conference
7/27/2009 11:10:51 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
7/24/2009 8:43:35 AM
More...
|
DellaCamera Makes Formal Request for Enzon Pharmaceuticals, Inc. (ENZN) to Set Record Date for Consent Solicitation
7/7/2009 11:44:37 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Commences Phase II Trial of PEG-SN38
6/23/2009 10:00:54 AM
More...
|
|